Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$148M |
| 2 |
Mondelez International
MDLZ
|
+$144M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$53.4M |
| 5 |
Microsoft
MSFT
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$225M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$91.6M |
| 4 |
Walmart Inc
WMT
|
+$87.7M |
| 5 |
JPMorgan Chase
JPM
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.71% |
| 2 | Healthcare | 20.65% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Financials | 7.63% |
| 5 | Technology | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $659K | ﹤0.01% |
7,497
| – | – |
|
752
Sensata Technologies
ST
$6.79B
| $644K | ﹤0.01% |
17,271
+5,634
| +48% | +$236K |
|
|
BHVN
753
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $640K | ﹤0.01% |
4,232
-2,076
| -33% | -$308K |
|
754
Illumina
ILMN
$28.4B
| $632K | ﹤0.01% |
3,403
-5,146
| -60% | -$1.02M |
|
755
Alkermes
ALKS
$8.25B
| $630K | ﹤0.01% |
28,226
-1,427
| -5% | -$37.1K |
|
756
Hilton Worldwide
HLT
$71.5B
| $626K | ﹤0.01% |
5,188
-9,101
| -64% | -$1.15M |
|
757
iShares MSCI South Korea ETF
EWY
$24.1B
| $618K | ﹤0.01% |
13,042
-241,534
| -95% | -$13.8M |
|
758
Albemarle
ALB
$15.5B
| $617K | ﹤0.01% |
2,333
-114,390
| -98% | -$29.1M |
|
759
ScottsMiracle-Gro
SMG
$3.66B
| $604K | ﹤0.01% |
14,128
-9,725
| -41% | -$698K |
|
760
Huntsman Corp
HUN
$1.77B
| $602K | ﹤0.01% |
+24,531
| New | +$690K |
|
761
Regal Rexnord
RRX
$11.9B
| $602K | ﹤0.01% |
4,286
+533
| +14% | +$71.6K |
|
762
Guidewire Software
GWRE
$14.2B
| $600K | ﹤0.01% |
+9,747
| New | +$704K |
|
|
API
763
Agora
API
$377M
| $598K | ﹤0.01% |
164,852
-6,660
| -4% | -$31.5K |
|
764
Hawaiian Electric Industries
HE
$2.14B
| $596K | ﹤0.01% |
17,183
-2,121
| -11% | -$85.4K |
|
765
IQVIA
IQV
$39.3B
| $586K | ﹤0.01% |
3,235
-13,742
| -81% | -$3.01M |
|
766
MongoDB
MDB
$32.1B
| $561K | ﹤0.01% |
2,823
-1,768
| -39% | -$516K |
|
767
Fortune Brands Innovations
FBIN
$6.06B
| $550K | ﹤0.01% |
11,977
-177,586
| -94% | -$9.64M |
|
768
Tapestry
TPR
$32.8B
| $546K | ﹤0.01% |
19,220
-425,421
| -96% | -$14.2M |
|
769
Chewy
CHWY
$9.63B
| $545K | ﹤0.01% |
17,741
-13,071
| -42% | -$519K |
|
770
Bausch Health
BHC
$2.34B
| $541K | ﹤0.01% |
77,923
-13,385
| -15% | -$93K |
|
771
Alcoa
AA
$13.2B
| $519K | ﹤0.01% |
15,428
-64,641
| -81% | -$3.02M |
|
772
Spire
SR
$4.85B
| $516K | ﹤0.01% |
8,272
-864
| -9% | -$61.8K |
|
773
AutoNation
AN
$6.92B
| $514K | ﹤0.01% |
5,049
-51,851
| -91% | -$6.08M |
|
774
Ametek
AME
$58.2B
| $505K | ﹤0.01% |
4,452
-12,413
| -74% | -$1.49M |
|
775
Warner Music
WMG
$13.8B
| $504K | ﹤0.01% |
21,713
-13,483
| -38% | -$371K |
|
Similar funds
Ray Dalio's Q3 2022 Portfolio in Review
As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.
- Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
- Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
- Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
- Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
- Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
- Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.